{"component": "clause", "props": {"groups": [{"snippet_links": [{"key": "studies-and-tests", "type": "clause", "offset": [39, 56]}, {"key": "by-or-on-behalf-of", "type": "definition", "offset": [67, 85]}, {"key": "sponsored-by", "type": "definition", "offset": [90, 102]}, {"key": "the-company-has", "type": "clause", "offset": [149, 164]}, {"key": "package-and-the-prospectus", "type": "clause", "offset": [216, 242]}, {"key": "misstatement-of-material-fact", "type": "clause", "offset": [348, 377]}, {"key": "statements-not-misleading", "type": "clause", "offset": [434, 459]}, {"key": "knowledge-of", "type": "definition", "offset": [480, 492]}, {"key": "material-respect", "type": "definition", "offset": [631, 647]}, {"key": "the-studies", "type": "clause", "offset": [663, 674]}, {"key": "tests-and-trials", "type": "clause", "offset": [676, 692]}], "size": 11, "samples": [{"hash": "lliMFtTswe", "uri": "/contracts/lliMFtTswe#clinical-data", "label": "Underwriting Agreement (Invitae Corp)", "score": 32.0691299438, "published": true}, {"hash": "k8hYJSu3hm4", "uri": "/contracts/k8hYJSu3hm4#clinical-data", "label": "Underwriting Agreement (Invitae Corp)", "score": 31.2614650726, "published": true}, {"hash": "e28c0rpUeHN", "uri": "/contracts/e28c0rpUeHN#clinical-data", "label": "Underwriting Agreement (Invitae Corp)", "score": 30.1745376587, "published": true}], "snippet": "The descriptions of the results of any studies and tests conducted by or on behalf of, or sponsored by, the Company or its subsidiaries, or in which the Company has participated, that are described in the Disclosure Package and the Prospectus, or the results of which are referred to in the Disclosure Package and the Prospectus do not contain any misstatement of material fact or omit to state a material fact necessary to make such statements not misleading. The Company has no knowledge of any studies or tests not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Disclosure Package or Prospectus.", "hash": "679c55bfc0b24f7bbc4a69b9b2039372", "id": 1}, {"snippet_links": [{"key": "schedule-a", "type": "clause", "offset": [26, 36]}, {"key": "additional-research-program", "type": "clause", "offset": [163, 190]}, {"key": "collaborate-with", "type": "clause", "offset": [201, 217]}, {"key": "notwithstanding-the-foregoing", "type": "clause", "offset": [265, 294]}, {"key": "sole-discretion", "type": "definition", "offset": [353, 368]}, {"key": "in-good-faith", "type": "clause", "offset": [423, 436]}, {"key": "deliver-to", "type": "definition", "offset": [437, 447]}, {"key": "relevant-patent", "type": "definition", "offset": [472, 487]}, {"key": "regulatory-agencies", "type": "clause", "offset": [491, 510]}, {"key": "required-to-be-disclosed", "type": "clause", "offset": [577, 601]}, {"key": "regulatory-filings", "type": "definition", "offset": [619, 637]}, {"key": "in-respect-of", "type": "clause", "offset": [650, 663]}, {"key": "clinical-laboratory-improvement-amendments", "type": "definition", "offset": [691, 733]}, {"key": "united-states-of", "type": "definition", "offset": [784, 800]}, {"key": "laboratory-testing", "type": "definition", "offset": [801, 819]}, {"key": "centers-for-medicare-medicaid-services", "type": "definition", "offset": [840, 880]}, {"key": "administration-regulations", "type": "definition", "offset": [923, 949]}, {"key": "other-regulations", "type": "clause", "offset": [989, 1006]}, {"key": "other-jurisdictions", "type": "definition", "offset": [1031, 1050]}, {"key": "receipt-of", "type": "clause", "offset": [1093, 1103]}, {"key": "approval-or-clearance", "type": "clause", "offset": [1116, 1137]}, {"key": "licensed-product", "type": "clause", "offset": [1143, 1159]}], "size": 6, "samples": [{"hash": "dlLBMgafFmD", "uri": "/contracts/dlLBMgafFmD#clinical-data", "label": "Additional Sponsored Research Agreement (Med BioGene Inc.)", "score": 21.3997268677, "published": true}, {"hash": "cTNuu2fXHvr", "uri": "/contracts/cTNuu2fXHvr#clinical-data", "label": "Additional Sponsored Research Agreement (Med BioGene Inc.)", "score": 21.2108154297, "published": true}, {"hash": "ktyLfEBCrwK", "uri": "/contracts/ktyLfEBCrwK#clinical-data", "label": "Additional Sponsored Research Agreement (Med BioGene Inc.)", "score": 21.0, "published": true}], "snippet": "As more fully outlined in Schedule A, UHN shall utilize the Clinical Data (as such term is defined below in Subsection 5.1(a)) to undertake the analysis under the Additional Research Program and shall collaborate with MBI in analyzing the results of such analysis. Notwithstanding the foregoing, the disclosure to MBI of the raw Clinical Data is in the sole discretion of UHN. Also notwithstanding the foregoing, UHN shall in good faith deliver to MBI, or directly to the relevant patent or regulatory agencies under assurances of confidentiality, the Clinical Data reasonably required to be disclosed in any Patent or regulatory filings, including, in respect of the latter, that under the Clinical Laboratory Improvement Amendments regulations and program for the regulation in the United States of laboratory testing administered by the Centers for Medicare & Medicaid Services (CMS), or the United States Food and Drug Administration regulations, or any successor agencies thereof, or other regulations in the United States or other jurisdictions, in respect of the submission for, or the receipt of, regulatory approval or clearance of a Licensed Product.", "hash": "993a556e579db1332a40e89256023809", "id": 4}, {"snippet_links": [{"key": "notwithstanding-the-foregoing", "type": "clause", "offset": [0, 29]}, {"key": "clinical-data-and-results", "type": "definition", "offset": [57, 82]}, {"key": "this-agreement", "type": "clause", "offset": [99, 113]}], "size": 3, "samples": [{"hash": "5GwZ2etLeZE", "uri": "/contracts/5GwZ2etLeZE#clinical-data", "label": "Collaboration and License Agreement (Codiak BioSciences, Inc.)", "score": 31.5954818726, "published": true}, {"hash": "biCdK9gVxD5", "uri": "/contracts/biCdK9gVxD5#clinical-data", "label": "Collaboration and License Agreement (Codiak BioSciences, Inc.)", "score": 30.3223819733, "published": true}, {"hash": "eH1lvV22kzn", "uri": "/contracts/eH1lvV22kzn#clinical-data", "label": "Collaboration and License Agreement (Codiak BioSciences, Inc.)", "score": 30.2183437347, "published": true}], "snippet": "Notwithstanding the foregoing, Jazz shall solely own all clinical data and results generated under this Agreement.", "hash": "d15627d376dcefcb783ca209a8bbc62f", "id": 10}, {"snippet_links": [{"key": "upon-closing", "type": "clause", "offset": [0, 12]}, {"key": "seller-shall", "type": "clause", "offset": [14, 26]}, {"key": "to-buyer", "type": "definition", "offset": [144, 152]}, {"key": "related-to", "type": "definition", "offset": [172, 182]}, {"key": "cv-products", "type": "definition", "offset": [187, 198]}, {"key": "contained-in", "type": "definition", "offset": [212, 224]}, {"key": "possession-or-control", "type": "definition", "offset": [269, 290]}], "size": 8, "samples": [{"hash": "7vHwBgK7CUx", "uri": "/contracts/7vHwBgK7CUx#clinical-data", "label": "Asset Purchase Agreement (Biotech Spinco, Inc.)", "score": 21.0, "published": true}, {"hash": "7cUGU5txRl3", "uri": "/contracts/7cUGU5txRl3#clinical-data", "label": "Asset Purchase Agreement (PDL Biopharma, Inc.)", "score": 21.0, "published": true}, {"hash": "6ie2YGZFUq7", "uri": "/contracts/6ie2YGZFUq7#clinical-data", "label": "Asset Purchase Agreement (Facet Biotech Corp)", "score": 21.0, "published": true}], "snippet": "Upon Closing, Seller shall sell, transfer, assign, convey and deliver, or shall cause to be sold, transferred, assigned, conveyed and delivered to Buyer, all clinical data related to the CV Products and which is contained in Seller\u2019s databases or otherwise in Seller\u2019s possession or control (the \u201cClinical Data\u201d).", "hash": "88ef7f9ac2447392cdb6cd032bc68226", "id": 2}, {"snippet_links": [{"key": "agreements-with-third-parties", "type": "clause", "offset": [7, 36]}, {"key": "development-of", "type": "clause", "offset": [79, 93]}, {"key": "collaboration-product", "type": "clause", "offset": [129, 150]}, {"key": "access-to", "type": "definition", "offset": [275, 284]}, {"key": "to-the-extent", "type": "clause", "offset": [300, 313]}, {"key": "health-and-welfare", "type": "definition", "offset": [403, 421]}, {"key": "the-us", "type": "clause", "offset": [423, 430]}, {"key": "commission-of", "type": "clause", "offset": [441, 454]}, {"key": "proprietary-medicines", "type": "definition", "offset": [455, 476]}, {"key": "european-community", "type": "clause", "offset": [484, 502]}, {"key": "evaluation-agency", "type": "definition", "offset": [527, 544]}, {"key": "regulatory-agency", "type": "clause", "offset": [554, 571]}, {"key": "each-case", "type": "definition", "offset": [576, 585]}, {"key": "with-respect-to", "type": "clause", "offset": [586, 601]}, {"key": "regulatory-approvals", "type": "clause", "offset": [602, 622]}], "size": 4, "samples": [{"hash": "f1lggKxC37r", "uri": "/contracts/f1lggKxC37r#clinical-data", "label": "Collaboration Agreement (Biomarin Pharmaceutical Inc)", "score": 18.0, "published": true}, {"hash": "d4OA33ptYLs", "uri": "/contracts/d4OA33ptYLs#clinical-data", "label": "Collaboration Agreement (Biomarin Pharmaceutical Inc)", "score": 18.0, "published": true}], "snippet": "In all agreements with Third Parties or Affiliates ------------- involving the development of preclinical or clinical data for a Collaboration Product, Genzyme and BioMarin shall require that such Third Parties and Affiliates provide BioMarin/Genzyme LLC and the other Party access to all such data, to the extent such data is required to be obtained from such Third Parties by the Japanese Ministry of Health and Welfare, the U.S. FDA, the Commission of Proprietary Medicines of the European Community, the European Medicines Evaluation Agency or other regulatory agency, in each case with respect to Regulatory Approvals.", "hash": "3a61e45bfbebe3f2c55670b0984467bf", "id": 7}, {"snippet_links": [{"key": "all-records", "type": "clause", "offset": [0, 11]}, {"key": "laboratory-notebooks", "type": "clause", "offset": [69, 89]}, {"key": "written-materials", "type": "clause", "offset": [141, 158]}, {"key": "related-to", "type": "definition", "offset": [159, 169]}, {"key": "clinical-studies", "type": "clause", "offset": [182, 198]}, {"key": "relating-to", "type": "definition", "offset": [199, 210]}, {"key": "backup-compound", "type": "definition", "offset": [229, 244]}, {"key": "china-territory", "type": "definition", "offset": [269, 284]}], "size": 6, "samples": [{"hash": "6Wd6l08rTFX", "uri": "/contracts/6Wd6l08rTFX#clinical-data", "label": "Asset Purchase Agreement (Roivant Sciences Ltd.)", "score": 32.364818573, "published": true}, {"hash": "lPGh7edMnRh", "uri": "/contracts/lPGh7edMnRh#clinical-data", "label": "Asset Purchase Agreement (Dermavant Sciences LTD)", "score": 30.3908290863, "published": true}, {"hash": "eWRnlVTY37Z", "uri": "/contracts/eWRnlVTY37Z#clinical-data", "label": "Asset Purchase Agreement (Dermavant Sciences LTD)", "score": 30.1882266998, "published": true}], "snippet": "All Records, data, documents, correspondence, lists, specifications, laboratory notebooks, protocols, studies, reports, and other printed or written materials related to any and all clinical studies relating to the Compound, any Backup Compound or any Products for the China Territory.", "hash": "34a57193b832c8f37a78bfdb242c7b51", "id": 3}, {"snippet_links": [{"key": "the-studies", "type": "clause", "offset": [0, 11]}, {"key": "tests-and-preclinical-and-clinical-trials", "type": "clause", "offset": [13, 54]}, {"key": "sponsored-by", "type": "definition", "offset": [69, 81]}, {"key": "to-the-company", "type": "definition", "offset": [86, 100]}, {"key": "the-company-and-its-subsidiaries", "type": "clause", "offset": [137, 169]}, {"key": "the-registration-statement", "type": "clause", "offset": [192, 218]}, {"key": "time-of-sale-prospectus", "type": "definition", "offset": [224, 247]}, {"key": "the-prospectus", "type": "clause", "offset": [252, 266]}, {"key": "being-conducted", "type": "definition", "offset": [434, 449]}, {"key": "in-all-material-respects", "type": "definition", "offset": [450, 474]}, {"key": "with-applicable-laws", "type": "clause", "offset": [489, 509]}, {"key": "without-limitation", "type": "clause", "offset": [522, 540]}, {"key": "rules-and-regulations", "type": "clause", "offset": [590, 611]}, {"key": "tests-and-trials", "type": "clause", "offset": [712, 728]}, {"key": "regulatory-status", "type": "clause", "offset": [764, 781]}, {"key": "contained-in", "type": "definition", "offset": [783, 795]}, {"key": "accurate-and-complete", "type": "clause", "offset": [875, 896]}, {"key": "the-data", "type": "clause", "offset": [941, 949]}, {"key": "except-to-the-extent", "type": "clause", "offset": [995, 1015]}, {"key": "the-study", "type": "definition", "offset": [1214, 1223]}, {"key": "trial-results", "type": "clause", "offset": [1234, 1247]}, {"key": "the-context", "type": "clause", "offset": [1366, 1377]}, {"key": "state-of", "type": "definition", "offset": [1431, 1439]}, {"key": "the-company-has", "type": "clause", "offset": [1568, 1583]}, {"key": "the-fda", "type": "clause", "offset": [1632, 1639]}, {"key": "governmental-authority", "type": "clause", "offset": [1653, 1675]}, {"key": "termination-or-suspension-of", "type": "clause", "offset": [1690, 1718]}, {"key": "ordinary-course", "type": "definition", "offset": [2064, 2079]}, {"key": "with-respect-to", "type": "clause", "offset": [2095, 2110]}, {"key": "in-connection-with", "type": "clause", "offset": [2125, 2143]}, {"key": "design-and-implementation", "type": "clause", "offset": [2148, 2173]}, {"key": "any-action", "type": "definition", "offset": [2318, 2328]}, {"key": "to-place", "type": "definition", "offset": [2329, 2337]}, {"key": "hold-order", "type": "definition", "offset": [2349, 2359]}], "size": 5, "samples": [{"hash": "66iIK6ZEZ1c", "uri": "/contracts/66iIK6ZEZ1c#clinical-data", "label": "Underwriting Agreement (Travere Therapeutics, Inc.)", "score": 33.8528404236, "published": true}, {"hash": "5n45FW0VsZq", "uri": "/contracts/5n45FW0VsZq#clinical-data", "label": "Underwriting Agreement (Travere Therapeutics, Inc.)", "score": 32.1608505249, "published": true}, {"hash": "2Ct0fVqHw1r", "uri": "/contracts/2Ct0fVqHw1r#clinical-data", "label": "Underwriting Agreement (Retrophin, Inc.)", "score": 31.4366874695, "published": true}], "snippet": "The studies, tests and preclinical and clinical trials conducted by, sponsored by or, to the Company\u2019s knowledge, conducted on behalf of the Company and its subsidiaries that are described in the Registration Statement, the Time of Sale Prospectus and the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Prospectus and the Prospectus, as applicable, were and, if still ongoing, are being conducted in all material respects in accordance with Applicable Laws, including, without limitation, the Federal Food, Drug and Cosmetic Act and the rules and regulations promulgated thereunder at 21 C.F.R. Parts 50, 54, 56, 58 and 312; the descriptions of such studies, tests and trials, including any related results and regulatory status, contained in the Registration Statement, the Time of Sale Prospectus and the Prospectus are accurate and complete in all material respects and fairly present the data derived from such studies, tests and trials; except to the extent disclosed in the Registration Statement, the Time of Sale Prospectus and the Prospectus, the Company is not aware of any studies, tests or trials, the results of which reasonably call into question the study, test, or trial results described or referred to in the Registration Statement, the Time of Sale Prospectus and the Prospectus when viewed in the context in which such results are described and the clinical state of development; and, except to the extent disclosed in the Registration Statement, the Time of Sale Prospectus and the Prospectus, the Company has not received any notices or correspondence from the FDA or any other Governmental Authority requiring the termination or suspension of any studies, tests or preclinical or clinical trials conducted by, sponsored by or conducted on behalf of the Company that are described in the Registration Statement, the Time of Sale Prospectus and the Prospectus or the results of which are referred to in the Registration Statement, the Time of Sale Prospectus and the Prospectus, other than ordinary course communications with respect to modifications in connection with the design and implementation of such trials, and neither the FDA nor any other Governmental Authority has commenced, or, to the Company\u2019s knowledge, threatened to initiate, any action to place a clinical hold order on, or otherwise terminate, delay or suspend such studies, tests or preclinical or clinical trials.", "hash": "23e6e02dfe0cbc99d44aab1c60dc14a9", "id": 5}, {"snippet_links": [{"key": "knowledge-of-the-company", "type": "clause", "offset": [7, 31]}, {"key": "the-research", "type": "clause", "offset": [33, 45]}, {"key": "studies-and-tests", "type": "clause", "offset": [47, 64]}, {"key": "behalf-of-the-company", "type": "clause", "offset": [84, 105]}, {"key": "being-conducted", "type": "definition", "offset": [143, 158]}, {"key": "reasonable-care", "type": "definition", "offset": [164, 179]}, {"key": "in-accordance-with", "type": "definition", "offset": [184, 202]}, {"key": "procedures-and-controls", "type": "clause", "offset": [227, 250]}, {"key": "pursuant-to", "type": "clause", "offset": [251, 262]}, {"key": "laws-and-authorizations", "type": "clause", "offset": [279, 302]}, {"key": "contained-in", "type": "definition", "offset": [372, 384]}, {"key": "the-registration-statement", "type": "clause", "offset": [385, 411]}, {"key": "time-of-sale-prospectus", "type": "definition", "offset": [417, 440]}, {"key": "the-prospectus", "type": "clause", "offset": [445, 459]}, {"key": "accurate-and-complete", "type": "clause", "offset": [464, 485]}, {"key": "in-all-material-respects", "type": "definition", "offset": [486, 510]}, {"key": "the-data", "type": "clause", "offset": [530, 538]}, {"key": "except-to-the-extent", "type": "clause", "offset": [587, 607]}, {"key": "test-results", "type": "definition", "offset": [852, 864]}, {"key": "the-context", "type": "clause", "offset": [983, 994]}, {"key": "the-company-has", "type": "clause", "offset": [1032, 1047]}, {"key": "governmental-authority", "type": "clause", "offset": [1100, 1122]}, {"key": "the-termination", "type": "clause", "offset": [1133, 1148]}, {"key": "modification-of", "type": "clause", "offset": [1173, 1188]}, {"key": "no-adverse", "type": "clause", "offset": [1308, 1318]}, {"key": "resulting-from", "type": "definition", "offset": [1345, 1359]}], "size": 4, "samples": [{"hash": "gphakGCZxbT", "uri": "/contracts/gphakGCZxbT#clinical-data", "label": "Underwriting Agreement (Marinus Pharmaceuticals Inc)", "score": 29.937713623, "published": true}, {"hash": "krkTMnTQnBw", "uri": "/contracts/krkTMnTQnBw#clinical-data", "label": "Underwriting Agreement (Marinus Pharmaceuticals Inc)", "score": 29.4065704346, "published": true}, {"hash": "1TfxEb5dLWZ", "uri": "/contracts/1TfxEb5dLWZ#clinical-data", "label": "Underwriting Agreement (Marinus Pharmaceuticals Inc)", "score": 28.9466114044, "published": true}], "snippet": "To the knowledge of the Company, the research, studies and tests conducted by or on behalf of the Company have been and, if still pending, are being conducted with reasonable care and in accordance with experimental protocols, procedures and controls pursuant to all Health Care Laws and Authorizations; the descriptions of the results of such research, studies and tests contained in the Registration Statement, the Time of Sale Prospectus and the Prospectus are accurate and complete in all material respects and fairly present the data derived from such research, studies, and tests; except to the extent disclosed in the Registration Statement, the Time of Sale Prospectus and the Prospectus, the Company is not aware of any research, studies or tests, the results of which the Company believes reasonably call into question the research, study or test results described or referred to in the Registration Statement, the Time of Sale Prospectus and the Prospectus when viewed in the context in which such results are described; the Company has not received any notices or correspondence from any Governmental Authority requiring the termination, suspension or material modification of any research, study or test conducted by or on behalf of the Company. To the knowledge of the Company, there have been no adverse episodes or complications resulting from any research, study or test conducted by or on behalf of the Company.", "hash": "5d6a685ada3904c5a87e49dca6f0ee9e", "id": 6}, {"snippet_links": [{"key": "to-the-extent", "type": "clause", "offset": [0, 13]}, {"key": "applicable-law", "type": "clause", "offset": [27, 41]}, {"key": "regulations-and-rules", "type": "clause", "offset": [43, 64]}, {"key": "each-party", "type": "clause", "offset": [66, 76]}, {"key": "other-party", "type": "definition", "offset": [98, 109]}, {"key": "providing-party", "type": "clause", "offset": [153, 168]}, {"key": "related-to", "type": "definition", "offset": [234, 244]}, {"key": "within-thirty", "type": "clause", "offset": [271, 284]}, {"key": "reference-rights", "type": "clause", "offset": [403, 419]}, {"key": "regulatory-filings-and-regulatory-approvals", "type": "clause", "offset": [423, 466]}, {"key": "the-products", "type": "clause", "offset": [510, 522]}, {"key": "right-to-access", "type": "clause", "offset": [561, 576]}], "size": 3, "samples": [{"hash": "aNeoDBcN6f", "uri": "/contracts/aNeoDBcN6f#clinical-data", "label": "License Agreement", "score": 31.3408622742, "published": true}, {"hash": "93WXSwcA8DU", "uri": "/contracts/93WXSwcA8DU#clinical-data", "label": "License Agreement (Orthovita Inc)", "score": 21.0, "published": true}, {"hash": "4QZFFT588bH", "uri": "/contracts/4QZFFT588bH#clinical-data", "label": "License Agreement (Orthovita Inc)", "score": 21.0, "published": true}], "snippet": "To the extent permitted by applicable law, regulations and rules, each Party shall provide to the other Party any and all Clinical Data obtained by such providing Party or its Affiliates, but only to the extent such Clinical Data are related to Products and Accessories, within thirty (30) days of the obtaining or generation of any such Clinical Data. Each Party hereby grants to the other Party cross-reference rights to Regulatory Filings and Regulatory Approvals that include such Clinical Data related to the Products and/or Accessories, together with the right to access the same.", "hash": "16116a09d054d627246ace478367ef69", "id": 8}, {"snippet_links": [{"key": "any-reference-to", "type": "clause", "offset": [20, 36]}, {"key": "the-definitions-of", "type": "definition", "offset": [58, 76]}, {"key": "licensed-products", "type": "definition", "offset": [77, 94]}, {"key": "in-this-agreement", "type": "definition", "offset": [130, 147]}, {"key": "the-parties-acknowledge-and-agree-that", "type": "clause", "offset": [149, 187]}, {"key": "scope-of", "type": "clause", "offset": [196, 204]}, {"key": "the-licensee-may", "type": "clause", "offset": [231, 247]}, {"key": "set-out", "type": "definition", "offset": [285, 292]}, {"key": "agreement-between", "type": "clause", "offset": [319, 336]}, {"key": "imperial-college", "type": "definition", "offset": [354, 370]}, {"key": "no-right", "type": "clause", "offset": [381, 389]}], "size": 3, "samples": [{"hash": "1gLDjN9uQkU", "uri": "/contracts/1gLDjN9uQkU#clinical-data", "label": "Intellectual Property Licence Agreement (Metsera, Inc.)", "score": 35.2306632996, "published": true}, {"hash": "k5IzOx11iDN", "uri": "/contracts/k5IzOx11iDN#clinical-data", "label": "Intellectual Property Licence Agreement (Metsera, Inc.)", "score": 35.0253257751, "published": true}, {"hash": "i8wWUKAwcnL", "uri": "/contracts/i8wWUKAwcnL#clinical-data", "label": "Intellectual Property Licence Agreement (Metsera, Inc.)", "score": 34.9459266663, "published": true}], "snippet": "(a) Notwithstanding any reference to the Clinical Data in the definitions of Licensed Products and Know-How Products or elsewhere in this Agreement, the Parties acknowledge and agree that (i) the scope of any right or licence that the Licensee may have under the Clinical Data will be set out solely in any Data Access Agreement between the Licensee and Imperial College, and (ii) no right or licence under any Clinical Data is granted under this Agreement.", "hash": "c2248971f515e31992a00ee2a6b96112", "id": 9}], "next_curs": "ClYSUGoVc35sYXdpbnNpZGVyY29udHJhY3RzcjILEhZDbGF1c2VTbmlwcGV0R3JvdXBfdjU2IhZjbGluaWNhbC1kYXRhIzAwMDAwMDBhDKIBAmVuGAAgAA==", "clause": {"children": [["insurance", "Insurance"], ["indemnification-by-sg", "Indemnification by SG"], ["notice", "Notice"], ["indemnification-by-gne", "Indemnification by GNE"], ["provision-of-clinical-data", "PROVISION OF CLINICAL DATA"]], "title": "Clinical Data", "parents": [["representations-and-warranties-of-the-company", "Representations and Warranties of the Company"], ["representations-and-warranties", "Representations and Warranties"], ["intellectual-property", "Intellectual Property"], ["purchase-and-sale-of-assets", "Purchase and Sale of Assets"], ["the-development-program", "The Development Program"]], "size": 167, "id": "clinical-data", "related": [["technical-data", "Technical Data", "Technical Data"], ["clinical", "Clinical", "Clinical"], ["clinical-data-and-regulatory-compliance", "Clinical Data and Regulatory Compliance", "<strong>Clinical Data</strong> and Regulatory Compliance"], ["product-data", "Product Data", "Product Data"], ["tests-and-preclinical-and-clinical-trials", "Tests and Preclinical and Clinical Trials", "Tests and Preclinical and Clinical Trials"]], "related_snippets": [], "updated": "2026-03-07T06:14:21+00:00", "also_ask": ["What are the essential elements to include in a Clinical Data clause to protect proprietary information?", "How can the clause be negotiated to balance sponsor control with investigator publication rights?", "What are the main legal risks if clinical data ownership or access is not clearly defined?", "How do Clinical Data clauses differ across jurisdictions, especially regarding data privacy and transfer?", "What standards do courts apply to determine enforceability of Clinical Data restrictions in disputes?"], "drafting_tip": "Define 'Clinical Data' precisely to avoid ambiguity; specify ownership and permitted uses to ensure enforceability and protect parties' interests.", "explanation": "The Clinical Data clause defines the rights and responsibilities regarding the collection, use, and management of data generated from clinical studies or trials. It typically outlines who owns the clinical data, how it may be accessed or shared, and any confidentiality or regulatory requirements that must be followed. For example, it may specify that the sponsor retains ownership of all data, while investigators are permitted to use de-identified results for academic publication. This clause ensures clarity over data ownership and usage, helping to prevent disputes and protect sensitive information."}, "json": true, "cursor": ""}}